| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-84 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-227
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1875 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00 |
| filingDate |
1994-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2000-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4631f6b362790345c973ac1402f6a85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66644ee5f15a9db2c349a0744f71ec3d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce61219aac506805ab5396469295a67e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edf1c45184185d8dc542070163e3fd33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd50784041adaa1482db8a03050d0cf7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff9df0b694ae22d9a3c5d4abce829ffa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56affea9ce8a5a3b509c7662e6cdb26c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a86445a0475f766415ae93a2e9cfaa99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_926dcd8ce80c8281ea6989efc3078450 |
| publicationDate |
2000-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2169362-C |
| titleOfInvention |
Formulations for delivery of osteogenic proteins |
| abstract |
A composition is disclosed comprising a pharmaceutically acceptable admixture of an osteogenic protein; a porous particulate polymer matrix; an osteogenic protein-sequestering amount of blood clot; and a calcium sulfate hemihydrate-containing substance. Also disclosed are formulations of bone morphogenetic proteins with improved solubility and/or stability characteristics. |
| priorityDate |
1993-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |